{"title":"挑战传统的研发理念","authors":"G. Favato, R. Mills","doi":"10.1177/174578660601800105","DOIUrl":null,"url":null,"abstract":"With discontinuity in technology, it can be frustrating to gauge its influence on Research and Development structure. What managers need, therefore, is a framework to help them understand significant advances in technology – something that will enable them to anticipate new innovation paradigms. This article examines the way that an explosion of biotechnologies has forced managers to question the relevance of the former pharmaceutical R&D model. For companies like Procter & Gamble, being able to recognise big discontinuities in the innovation model – and being proactive about implementing change strategies – has helped them reshape their innovation models whilst staying competitive.","PeriodicalId":102537,"journal":{"name":"Henley Manager Update","volume":"9 3 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2006-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"9","resultStr":"{\"title\":\"Challenging Conventional Wisdom in R&D\",\"authors\":\"G. Favato, R. Mills\",\"doi\":\"10.1177/174578660601800105\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"With discontinuity in technology, it can be frustrating to gauge its influence on Research and Development structure. What managers need, therefore, is a framework to help them understand significant advances in technology – something that will enable them to anticipate new innovation paradigms. This article examines the way that an explosion of biotechnologies has forced managers to question the relevance of the former pharmaceutical R&D model. For companies like Procter & Gamble, being able to recognise big discontinuities in the innovation model – and being proactive about implementing change strategies – has helped them reshape their innovation models whilst staying competitive.\",\"PeriodicalId\":102537,\"journal\":{\"name\":\"Henley Manager Update\",\"volume\":\"9 3 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2006-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"9\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Henley Manager Update\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1177/174578660601800105\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Henley Manager Update","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/174578660601800105","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
With discontinuity in technology, it can be frustrating to gauge its influence on Research and Development structure. What managers need, therefore, is a framework to help them understand significant advances in technology – something that will enable them to anticipate new innovation paradigms. This article examines the way that an explosion of biotechnologies has forced managers to question the relevance of the former pharmaceutical R&D model. For companies like Procter & Gamble, being able to recognise big discontinuities in the innovation model – and being proactive about implementing change strategies – has helped them reshape their innovation models whilst staying competitive.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
